Aktis Oncology
Founded 2020 · CIK 0002035832 · Biotech · Public
Miniprotein radioconjugates targeting tumor antigens for cancer therapy
aktisoncology.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $175M
- 1 Form D · Oct 2024
- 24 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 27
- 2 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $175,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1936 | CELLARCUS TECHNOLOGIES, LLC | — | — |
| 1937 | DeepSpace Storage Systems Inc. | — | $1.3M |
| 1938 | Centrexion Therapeutics Corp | — | $189M |
| 1939 | Aktis Oncology | — | $175M |
| 1940 | Quotient Ltd | — | $92M |
| 1941 | Myota, Inc. | — | $16M |
| 1942 | AXIOMX INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Todd FoleyDirector
- Ken HerrmannDirector
- Helen KimDirector
- Andrew LevinDirector
- Oleg NodelmanDirector
- Matthew RodenDirector · Executive Officer
- Shulamit Ron-BiggerExecutive Officer
- Lloyd SegalDirector
Patents
- B7-H3 Miniproteins, Conjugates, And Uses Thereofgranted
- Miniproteins, Conjugates & Uses Thereofapplication
- B7-H3 Miniproteins, Conjugates, And Uses Thereofapplication
- NECTIN-4 Miniprotein Conjugatesapplication
- Nectin-4 binding miniproteins, conjugates and methods of use thereofgranted
- B7H3 Miniprotein Conjugatesapplication
- B7H3 Miniprotein Conjugatesapplication
- B7H3 Miniprotein Conjugatesapplication
- Decoy Miniproteins, Compositions, & Methods Of Useapplication
- NECTIN-4 Miniprotein Conjugatesapplication
- B7H3 Miniprotein Conjugatesapplication
- NECTIN-4 Miniprotein Conjugatesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.